110 related articles for article (PubMed ID: 14561144)
41. Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: Insights into Ca2+-independent catalytic mechanism.
Corrêa LC; Marchi-Salvador DP; Cintra AC; Sampaio SV; Soares AM; Fontes MR
Biochim Biophys Acta; 2008 Apr; 1784(4):591-9. PubMed ID: 18261474
[TBL] [Abstract][Full Text] [Related]
42. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity.
Soares AM; Rodrigues VM; Homsi-Brandeburgo MI; Toyama MH; Lombardi FR; Arni RK; Giglio JR
Toxicon; 1998 Mar; 36(3):503-14. PubMed ID: 9637370
[TBL] [Abstract][Full Text] [Related]
43. Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom.
Calderón L; Lomonte B
Arch Biochem Biophys; 1998 Oct; 358(2):343-50. PubMed ID: 9784249
[TBL] [Abstract][Full Text] [Related]
44. Structural evidence for a fatty acid-independent myotoxic mechanism for a phospholipase A
Salvador GHM; Dos Santos JI; Borges RJ; Fontes MRM
Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):473-481. PubMed ID: 29287778
[TBL] [Abstract][Full Text] [Related]
45. Insights on calcium-independent phospholipid membrane damage by Lys49-PLA2 using tryptophan scanning mutagenesis of bothropstoxin-I from Bothrops jararacussu.
Ferreira TL; Ruller R; Chioato L; Ward RJ
Biochimie; 2008 Sep; 90(9):1397-406. PubMed ID: 18036350
[TBL] [Abstract][Full Text] [Related]
46. Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom.
Barbosa PS; Martins AM; Havt A; Toyama DO; Evangelista JS; Ferreira DP; Joazeiro PP; Beriam LO; Toyama MH; Fonteles MC; Monteiro HS
Toxicon; 2005 Sep; 46(4):376-86. PubMed ID: 16115661
[TBL] [Abstract][Full Text] [Related]
47. A micelle nucleation model for the interaction of dodecyl sulphate with Lys49-phospholipases A(2).
Bortoleto-Bugs RK; Bugs MR; Neto AA; Ward RJ
Biophys Chem; 2007 Jan; 125(1):213-20. PubMed ID: 16945473
[TBL] [Abstract][Full Text] [Related]
48. Structural, functional, and bioinformatics studies reveal a new snake venom homologue phospholipase A₂ class.
dos Santos JI; Cintra-Francischinelli M; Borges RJ; Fernandes CA; Pizzo P; Cintra AC; Braz AS; Soares AM; Fontes MR
Proteins; 2011 Jan; 79(1):61-78. PubMed ID: 20878713
[TBL] [Abstract][Full Text] [Related]
49. Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with rosmarinic acid.
dos Santos JI; Santos-Filho NA; Soares AM; Fontes MR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jun; 66(Pt 6):699-701. PubMed ID: 20516603
[TBL] [Abstract][Full Text] [Related]
50. Chemical denaturation of a homodimeric lysine-49 phospholipase A2: a stable dimer interface and a native monomeric intermediate.
Ruller R; Ferreira TL; de Oliveira AH; Ward RJ
Arch Biochem Biophys; 2003 Mar; 411(1):112-20. PubMed ID: 12590929
[TBL] [Abstract][Full Text] [Related]
51. Sequence of a cDNA encoding bothropstoxin I, a myotoxin from the venom of Bothrops jararacussu.
Ward RJ; Monesi N; Arni RK; Larson RE; Paço-Larson ML
Gene; 1995 Apr; 156(2):305-6. PubMed ID: 7758974
[TBL] [Abstract][Full Text] [Related]
52. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action.
Lomonte B; Angulo Y; Calderón L
Toxicon; 2003 Dec; 42(8):885-901. PubMed ID: 15019489
[TBL] [Abstract][Full Text] [Related]
53. Structural and functional characterization of myotoxin I, a Lys49 phospholipase A2 homologue from the venom of the snake Bothrops atrox.
Núñez V; Arce V; Gutiérrez JM; Lomonte B
Toxicon; 2004 Jul; 44(1):91-101. PubMed ID: 15225567
[TBL] [Abstract][Full Text] [Related]
54. Crystal structure of a phospholipase A
Salvador GH; Dos Santos JI; Lomonte B; Fontes MR
Biochimie; 2017 Feb; 133():95-102. PubMed ID: 28034717
[TBL] [Abstract][Full Text] [Related]
55. Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities.
Núñez CE; Angulo Y; Lomonte B
Toxicon; 2001 Oct; 39(10):1587-94. PubMed ID: 11478967
[TBL] [Abstract][Full Text] [Related]
56. Crystal structure of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 in the monomeric and dimeric states: insights into its oligomeric state.
Magro AJ; Murakami MT; Marcussi S; Soares AM; Arni RK; Fontes MR
Biochem Biophys Res Commun; 2004 Oct; 323(1):24-31. PubMed ID: 15351695
[TBL] [Abstract][Full Text] [Related]
57. Structural basis for low catalytic activity in Lys49 phospholipases A2--a hypothesis: the crystal structure of piratoxin II complexed to fatty acid.
Lee WH; da Silva Giotto MT; Marangoni S; Toyama MH; Polikarpov I; Garratt RC
Biochemistry; 2001 Jan; 40(1):28-36. PubMed ID: 11141053
[TBL] [Abstract][Full Text] [Related]
58. Crystallization and preliminary X-ray diffraction studies of BmooPLA2-I, a platelet-aggregation inhibitor and hypotensive phospholipase A2 from Bothrops moojeni venom.
Salvador GH; Marchi-Salvador DP; Silveira LB; Soares AM; Fontes MR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Aug; 67(Pt 8):900-2. PubMed ID: 21821890
[TBL] [Abstract][Full Text] [Related]
59. No role for enzymatic activity or dantrolene-sensitive Ca2+ stores in the muscular effects of bothropstoxin, a Lys49 phospholipase A2 myotoxin.
Rodrigues-Simioni L; Prado-Franceschi J; Cintra AC; Giglio JR; Jiang MS; Fletcher JE
Toxicon; 1995 Nov; 33(11):1479-89. PubMed ID: 8744987
[TBL] [Abstract][Full Text] [Related]
60. Crystallization and preliminary X-ray diffraction studies of Streptomyces phospholipase A2 in a calcium-binding form.
Matoba Y; Kumagai T; Sugiyama M
J Inorg Biochem; 2000 Nov; 82(1-4):221-3. PubMed ID: 11132631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
